This course is not available at this time
Return to Course LibraryCE InformationBibliography

Release Date:

Expiration Date:




Daniel J. A. Margolis, MD
Assistant Professor of Radiology
Co-Director, Prostate MR Imaging
David Geffen School of Medicine at UCLA




Prostate MRI Techniques and Reporting
for Biopsy, surgical, and radiation Therapy Planning

Recording of a live webinar presented on October 19, 2011

A certified one-hour webinar on prostate MRI techniques and reporting for biopsy, surgical, and radiation therapy planning for radiologists, urologists, and other healthcare professionals who treat patients with prostate disease.

Format: Archived Webinar
Credit:  1.0 AMA PRA Category 1
(Available for physician credit only)
Fee for Credit Certificate: $0

Click the ENROLL NOW icon to the left to view this program ONLINE.


Course Overview

This program will provide learners with a variety of prostate MRI cases.  Expert faculty will share their experience and approach to prostate MRI in their practice.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Define the role of MRI for prostate cancer detection, staging and surveillance
  • Apply protocol and acquisition techniques to acquire diagnostic MR images that assist urologists in treating men with prostate disease.
  • Develop interpretation strategies to compensate for the limitations of MRI in patients with prostate disease

Accreditation & Credit

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and International Center for Postgraduate Medical Education (ICPME). PIM is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.


How to Participate

There are no fees to participate in this activity. Each participant will need a computer with internet access.

  • Click the blue link. Complete the precourse evaluation and click SUBMIT.
  • Once the precourse evaluation is submitted, click on the blue link again to view the course.
  • Click on PLAYBACK. To view the streaming video, you may have to download the WebEx Player or Java.

Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.


To Apply for Credit

  • View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
  • At the conclusion of the lecture, close the WebEx Player window. You will be redirected to the ICPME website.
  • From the COURSE HOME page, click the buttons for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit.  You may take the test up to three times.
  • Upon receipt of a passing grade, you will receive instructions to print a credit certificate.

Faculty Biography

Dr. Margolis earned his medical degree from University of Southern California School of Medicine, followed by an internship in internal medicine at West Los Angeles Veteran's Administration Hospital. He completed his residency in Diagnostic Radiology at UCLA and a prestigious fellowship funded by the National Cancer Institute at Stanford University.

Dr. Margolis' clinical expertise is in prostate magnetic resonance imaging, colon cancer screening, and using non-invasive medical imaging as a "surrogate biomarker" for drug development. Working closely with his colleagues in Interventional Radiology at UCLA Dr. Margolis provides a liaison between clinical researchers and medical imaging, and provides his expertise in advanced cancer imaging to research new imaging techniques as potential surrogate biomarkers to determine which new drug therapies are effective weeks or months before their effect is clinically evident. This will allow cancer specialists to determine if their therapy is working, or if another therapy is needed, after only one or two doses. Eventually, these techniques may be able to determine which therapy is optimal for tumors otherwise similar in size and appearance on CT even before the first dose is given.


Disclosure Information

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported NO financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:


Daniel J. A. Margolis, MD

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino
Jan Hixon, RN, BSN, MA
Trace Hutchison, PharmD
Julia Kimball, RN, BSN
Samantha Mattiucci, PharmD
Victoria Phoenix, BS
Jan Schultz, RN, MSN, CCMEP
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME, and Merge do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME, and Merge. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


For questions regarding this program, please contact ICPME:
Phone: 607-257-5860







Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.